Two long years of Covid-19 pandemic: lasting questions for pharma and healthcare
Within one year after the WHO declared the pandemic dimension of Covid-19, scientific ingenuity and unprecedented clinical development efforts gave…
All articles by Alvaro Arjona
Alvaro Arjona
Alvaro Arjona is Editor-in-Chief at GlobalData Media, with extensive experience in leading editorial teams covering Pharma & Healthcare. Former Editorial Director of Thomson Reuters Drug News, Alvaro started his career making significant contributions to the field of Immunology at Yale School of Medicine. He has also led scientific communications at UCB Pharma and developed data-driven clinical intelligence products at Informa Pharma Intelligence.
-
-
Deconstructing the decentralised clinical trial continuum: who is doing what?
Much has been said about the boom of decentralised clinical trials (DCTs) over the past couple of years, but not enough…